Interpharm Holdings, Inc.
Interpharm Holdings, Inc. (IPAH) Stock Overview
Explore Interpharm Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
270.8K
P/E Ratio
-0.02
EPS (TTM)
$-0.09
ROE
-0.82%
IPAH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Interpharm Holdings, Inc. (IPAH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 270.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.